{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 462260501
| IUPAC_name = 4-hydroxy-''N''-[(''E'')-(5-nitrofuran-2-yl)methylideneamino]benzamide
| image = Nifuroxazide.svg
| width = 275

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|nifuroxazide}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 965-52-6
| ATC_prefix = A07
| ATC_suffix = AX03
| PubChem = 5337997
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4495115
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = PM5LI0P38J
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07111
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 244888

<!--Chemical data-->
| C=12 | H=9 | N=3 | O=5
| molecular_weight = 275.2 g/mol
| smiles = c1cc(O)ccc1C(=O)N/N=C/c2ccc(o2)[N+](=O)[O-]
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H9N3O5/c16-9-3-1-8(2-4-9)12(17)14-13-7-10-5-6-11(20-10)15(18)19/h1-7,16H,(H,14,17)/b13-7+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YCWSUKQGVSGXJO-NTUHNPAUSA-N
}}

'''Nifuroxazide''' ([[International Nonproprietary Name|INN]]) is an oral [[nitrofuran]] [[antibiotic]], patented since 1966<ref name="patent1966" /> and used to treat [[colitis]] and [[diarrhoea]] in humans and non-humans.<ref name="patent_nonhumans" />  It is sold under the brand names Ambatrol, Antinal, Bacifurane, Diafuryl(Turkey), PÃ©rabacticel (France), Antinal, Diax (Egypt), Nifrozid, Ercefuryl (Romania, Czech Republic, Russia), Erfuzide (Thailand), Endiex (Slovakia), Enterofuryl (Russia), Nifuroksazyd (Poland), Pentofuryl (Germany), Topron, Enterovid (Latin America), Eskapar (Mexico), Enterocolin (Bolivia), Apazid (Morocco) and Septidiaryl. It is sold in capsule form and also as a suspension. The pharmaceutical group [[GlaxoSmithKline plc]] (Previously known as SmithKline Beecham) claims that nifuroxazide is highly effective and the consumers' group [[Healthy Skepticism]] says that GlaxoSmithKline's claims have no scientific support.<ref name="healthy_skep_nifuroxazide" />

==History==
Maurice Claude Ernest Carron patented the drug in the United States in 1966.<ref name="patent1966">USPTO No. 3290213 |http://www.google.com/patents?id=f2dwAAAAEBAJ</ref> Subsequent patents issued to Germano Cagliero of Marxer S.p.A describe the use of nifuroxazide as an antibiotic used to treat livestock.<ref name="patent_nonhumans">USPTO No 4093746 |http://www.google.com/patents?vid=USPAT4093746</ref>

==Effectiveness in humans==
In 1997, in an [[Ivory Coast]] promotional leaflet, [[GlaxoSmithKline]] claimed that nifuroxazide (under the brand name "Ambatrol") is an anti-dehydration treatment, "neutralise[s] microbacterials" in diarrhoea, and has "a spectrum which covers most enteropathogenic microbacterials, Shigella, [[Escherichia coli]], [[Salmonella]], [[staphylococcus|Staphylococci]], Klebsiella, [[Yersinia]]".<ref name="healthy_skep_nifuroxazide">{{cite web| last =| first =| authorlink =| coauthors =| title =SmithKline Beecham Ambatrol (nifuroxazide)| work =| publisher =[[Healthy Skepticism]]| date =June 1997| url =http://www.healthyskepticism.org/global/malam/int/mi1997-05_06/ |format =| doi =| accessdate =2010-12-21 |archiveurl=http://www.webcitation.org/5v94v2FtL |archivedate=2010-12-21  |deadurl=no}}</ref> The international [[non-profit organisation]] [[Healthy Skepticism]], at the time using their former name, Medical Lobby for Appropriate Marketing (MaLAM), disagreed, stating "We have not found any scientific evidence to support these claims."<ref name="healthy_skep_nifuroxazide" />

==Notes==
{{Reflist}}

{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}

==External links==


[[Category:Antibiotics]]
[[Category:Hydrazides]]
[[Category:Phenols]]
[[Category:Nitrofurans]]


{{antibiotic-stub}}
{{gastrointestinal-drug-stub}}